Lantheus Stock Price, News & Analysis (NASDAQ:LNTH)

$22.80 0.20 (0.88 %)
(As of 01/22/2018 01:10 PM ET)
Previous Close$22.60
Today's Range$22.35 - $22.85
52-Week Range$7.95 - $24.10
Volume214,300 shs
Average Volume291,923 shs
Market Capitalization$855.14 million
P/E Ratio28.15
Dividend YieldN/A
Beta0.94

About Lantheus (NASDAQ:LNTH)

Lantheus logoLantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

Receive LNTH News and Ratings via Email

Sign-up to receive the latest news and ratings for LNTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic & Testing Substances
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LNTH
CUSIPN/A
Phone978-671-8001

Debt

Debt-to-Equity Ratio-3.41%
Current Ratio2.96%
Quick Ratio2.46%

Price-To-Earnings

Trailing P/E Ratio28.1481481481481
Forward P/E Ratio21.71
P/E Growth1.48

Sales & Book Value

Annual Sales$301.85 million
Price / Sales2.83
Cash Flow$1.18 per share
Price / Cash19.30
Book Value($2.90) per share
Price / Book-7.86

Profitability

Trailing EPS$0.81
Net Income$26.76 million
Net Margins9.59%
Return on Equity-46.45%
Return on Assets16.42%

Miscellaneous

Employees465
Outstanding Shares37,510,000

Lantheus (NASDAQ:LNTH) Frequently Asked Questions

What is Lantheus' stock symbol?

Lantheus trades on the NASDAQ under the ticker symbol "LNTH."

How were Lantheus' earnings last quarter?

Lantheus Holdings Inc (NASDAQ:LNTH) announced its earnings results on Thursday, November, 2nd. The medical equipment provider reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. The medical equipment provider earned $79.94 million during the quarter, compared to analysts' expectations of $77.18 million. Lantheus had a negative return on equity of 46.45% and a net margin of 9.59%. The business's revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.15 EPS. View Lantheus' Earnings History.

Where is Lantheus' stock going? Where will Lantheus' stock price be in 2018?

4 analysts have issued 12-month target prices for Lantheus' shares. Their forecasts range from $22.00 to $27.00. On average, they expect Lantheus' share price to reach $24.00 in the next twelve months. View Analyst Ratings for Lantheus.

Are investors shorting Lantheus?

Lantheus saw a drop in short interest during the month of December. As of December 29th, there was short interest totalling 468,011 shares, a drop of 64.7% from the December 15th total of 1,324,332 shares. Based on an average trading volume of 303,775 shares, the short-interest ratio is currently 1.5 days. Approximately 1.3% of the shares of the stock are sold short.

Who are some of Lantheus' key competitors?

Who are Lantheus' key executives?

Lantheus' management team includes the folowing people:

  • Mary Anne Heino, President, Chief Executive Officer, Director (Age 57)
  • John W. Crowley, Chief Financial Officer, Treasurer (Age 53)
  • Michael P. Duffy, Senior Vice President, Strategy and Business Development, General Counsel and Secretary (Age 55)
  • Timothy Healey, Senior Vice President, Commercial (Age 51)
  • William C. Dawes JR, Vice President - Manufacturing and Operations (Age 45)
  • Carol Walker, Vice President, Quality (Age 54)
  • Simon Robinson, Vice President - Research & Pharmaceutical Development (Age 57)
  • Cesare Orlandi M.D., Chief Medical Officer (Age 67)
  • Brian A. Markison, Non-Executive Independent Chairman (Age 58)
  • Julie H. McHugh, Director (Age 52)

When did Lantheus IPO?

(LNTH) raised $75 million in an initial public offering on Thursday, June 25th 2015. The company issued 7,900,000 shares at a price of $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Who owns Lantheus stock?

Lantheus' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (2.78%), Schwab Charles Investment Management Inc. (0.48%), Fox Run Management L.L.C. (0.06%), Atria Investments LLC (0.04%) and Bank of Montreal Can (0.02%). Company insiders that own Lantheus stock include Avista Capital Partners Gp, Ll, Cesare Orlandi, David F Burgstahler, Derace L Schaffer, John W Crowley, Mary Anne Heino, Michael P Duffy and Timothy G Healey. View Institutional Ownership Trends for Lantheus.

Who sold Lantheus stock? Who is selling Lantheus stock?

Lantheus' stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC. Company insiders that have sold Lantheus company stock in the last year include Avista Capital Partners Gp, Ll, Cesare Orlandi, David F Burgstahler, Derace L Schaffer, John W Crowley, Mary Anne Heino, Michael P Duffy and Timothy G Healey. View Insider Buying and Selling for Lantheus.

Who bought Lantheus stock? Who is buying Lantheus stock?

Lantheus' stock was acquired by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Fox Run Management L.L.C., Atria Investments LLC and Bank of Montreal Can. View Insider Buying and Selling for Lantheus.

How do I buy Lantheus stock?

Shares of Lantheus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lantheus' stock price today?

One share of Lantheus stock can currently be purchased for approximately $22.80.

How big of a company is Lantheus?

Lantheus has a market capitalization of $855.14 million and generates $301.85 million in revenue each year. The medical equipment provider earns $26.76 million in net income (profit) each year or $0.81 on an earnings per share basis. Lantheus employs 465 workers across the globe.

How can I contact Lantheus?

Lantheus' mailing address is 331 TREBLE COVE ROAD, NORTH BILLERICA MA, 01862. The medical equipment provider can be reached via phone at 978-671-8001 or via email at [email protected]


MarketBeat Community Rating for Lantheus (LNTH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  153 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  285
MarketBeat's community ratings are surveys of what our community members think about Lantheus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Lantheus (NASDAQ:LNTH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.752.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.00$24.00$18.75$15.25
Price Target Upside: 6.19% upside6.19% upside0.27% upside13.11% downside

Lantheus (NASDAQ:LNTH) Consensus Price Target History

Price Target History for Lantheus (NASDAQ:LNTH)

Lantheus (NASDAQ:LNTH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Jefferies GroupBoost Price TargetBuy$22.00 -> $27.00N/AView Rating Details
11/3/2017Credit Suisse GroupBoost Price TargetNeutral$19.00 -> $23.00N/AView Rating Details
11/2/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformN/AView Rating Details
7/17/2017Cantor FitzgeraldInitiated CoverageOverweight$22.00HighView Rating Details
11/8/2016Royal Bank of CanadaBoost Price TargetOutperform$6.00 -> $12.00N/AView Rating Details
4/11/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
(Data available from 1/22/2016 forward)

Earnings

Lantheus (NASDAQ:LNTH) Earnings History and Estimates Chart

Earnings by Quarter for Lantheus (NASDAQ:LNTH)

Lantheus (NASDAQ LNTH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017Q3 2017$0.20$0.24$77.18 million$79.94 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.24$0.42$80.56 million$88.83 millionViewListenView Earnings Details
5/2/2017Q1 2017$0.19$0.28$77.75 million$81.36 millionViewListenView Earnings Details
2/21/2017Q416$0.13$0.18$70.78 million$74.35 millionViewListenView Earnings Details
11/1/2016Q3 2016$0.08$0.15ViewN/AView Earnings Details
8/4/2016Q216$0.06$0.24$72.66 million$78.00 millionViewListenView Earnings Details
5/3/2016Q116$0.06$0.15$72.43 million$76.50 millionViewListenView Earnings Details
2/22/2016Q415$0.02$0.13$71.47 million$71.00 millionViewListenView Earnings Details
11/4/2015Q315$0.04$0.18$73.65 million$74.10 millionViewListenView Earnings Details
8/4/2015Q215($0.14)$0.05$72.41 million$73.30 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Lantheus (NASDAQ:LNTH) Earnings Estimates

Current Year EPS Consensus Estimate: $1.05 EPS
Next Year EPS Consensus Estimate: $1.29 EPS

Dividends

Dividend History for Lantheus (NASDAQ:LNTH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Lantheus (NASDAQ LNTH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.30%
Institutional Ownership Percentage: 91.95%
Insider Trades by Quarter for Lantheus (NASDAQ:LNTH)
Institutional Ownership by Quarter for Lantheus (NASDAQ:LNTH)

Lantheus (NASDAQ LNTH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2018John W CrowleyCFOSell3,866$23.52$90,928.32View SEC Filing  
1/10/2018Michael P DuffyInsiderSell21,655$22.40$485,072.00156,784View SEC Filing  
11/17/2017Timothy G HealeySVPSell11,314$21.51$243,364.14View SEC Filing  
11/14/2017Michael P DuffyInsiderSell11,917$21.63$257,764.71152,301View SEC Filing  
10/13/2017John W CrowleyCFOSell6,755$18.41$124,359.55View SEC Filing  
9/13/2017Derace L SchafferDirectorSell15,000$17.50$262,500.0048,730View SEC Filing  
9/11/2017Michael P DuffyInsiderSell20,000$16.45$329,000.00184,218View SEC Filing  
9/7/2017David F BurgstahlerDirectorSell102,958$16.56$1,704,984.4813,248View SEC Filing  
9/6/2017David F BurgstahlerDirectorSell78,833$16.95$1,336,219.3513,248View SEC Filing  
9/5/2017Cesare OrlandiInsiderSell18,000$16.69$300,420.0087,078View SEC Filing  
9/5/2017David F BurgstahlerDirectorSell52,010$17.08$888,330.8013,248View SEC Filing  
9/1/2017David F BurgstahlerDirectorSell6,000$17.10$102,600.0013,248View SEC Filing  
8/31/2017David F BurgstahlerDirectorSell230,685$17.25$3,979,316.2513,248View SEC Filing  
8/28/2017David F BurgstahlerDirectorSell91,166$17.01$1,550,733.6613,248View SEC Filing  
8/16/2017Avista Capital Partners Gp, LlMajor ShareholderSell12,128$17.05$206,782.40View SEC Filing  
8/16/2017David F BurgstahlerDirectorSell140,846$17.27$2,432,410.4213,248View SEC Filing  
8/15/2017Avista Capital Partners Gp, LlMajor ShareholderSell40,779$17.06$695,689.74View SEC Filing  
8/14/2017Avista Capital Partners Gp, LlMajor ShareholderSell87,939$17.40$1,530,138.60View SEC Filing  
7/12/2017Mary Anne HeinoCEOSell10,000$18.05$180,500.00592,468View SEC Filing  
6/20/2017David F BurgstahlerDirectorSell3,000,000$14.87$44,610,000.00View SEC Filing  
6/12/2017Mary Anne HeinoCEOSell10,000$15.39$153,900.00602,468View SEC Filing  
6/12/2017Michael P DuffyInsiderSell20,000$15.42$308,400.00188,234View SEC Filing  
5/10/2017Derace L SchafferDirectorSell10,000$15.75$157,500.0063,730View SEC Filing  
5/9/2017Avista Capital Partners Gp, LlMajor ShareholderSell3,000,000$13.40$40,200,000.00View SEC Filing  
5/9/2017Derace L SchafferDirectorSell10,000$14.75$147,500.0073,730View SEC Filing  
3/17/2017David F BurgstahlerDirectorSell3,000,000$12.20$36,600,000.00View SEC Filing  
11/21/2016David F BurgstahlerDirectorSell2,500,000$9.00$22,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Lantheus (NASDAQ LNTH) News Headlines

Source:
DateHeadline
Insider Selling: Lantheus Holdings Inc (LNTH) CFO Sells 3,866 Shares of StockInsider Selling: Lantheus Holdings Inc (LNTH) CFO Sells 3,866 Shares of Stock
www.americanbankingnews.com - January 18 at 7:58 PM
Lantheus (LNTH) Upgraded to "Buy" by Zacks Investment ResearchLantheus (LNTH) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - January 18 at 6:14 AM
 Analysts Anticipate Lantheus Holdings Inc (LNTH) Will Post Quarterly Sales of $78.45 Million Analysts Anticipate Lantheus Holdings Inc (LNTH) Will Post Quarterly Sales of $78.45 Million
www.americanbankingnews.com - January 17 at 7:16 PM
Lantheus (LNTH) Lowered to Hold at Zacks Investment ResearchLantheus (LNTH) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 17 at 6:10 AM
Lantheus (LNTH) Upgraded to Buy at Zacks Investment ResearchLantheus (LNTH) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - January 14 at 7:27 PM
Short Interest in Lantheus Holdings Inc (LNTH) Decreases By 64.7%Short Interest in Lantheus Holdings Inc (LNTH) Decreases By 64.7%
www.americanbankingnews.com - January 14 at 3:38 AM
Lantheus Holdings Inc (LNTH) Receives Average Recommendation of "Buy" from AnalystsLantheus Holdings Inc (LNTH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 14 at 1:52 AM
Lantheus Holdings Inc (LNTH) Insider Sells $485,072.00 in StockLantheus Holdings Inc (LNTH) Insider Sells $485,072.00 in Stock
www.americanbankingnews.com - January 12 at 6:58 PM
Quotidian Technical Highlights on Selected Medical Equipment ... - PR Newswire (press release)Quotidian Technical Highlights on Selected Medical Equipment ... - PR Newswire (press release)
www.prnewswire.com - January 3 at 9:13 AM
Lantheus Holdings Inc (LNTH) Expected to Post Quarterly Sales of $78.45 MillionLantheus Holdings Inc (LNTH) Expected to Post Quarterly Sales of $78.45 Million
www.americanbankingnews.com - December 31 at 12:26 PM
Short Interest in Lantheus Holdings Inc (LNTH) Increases By 75.4%Short Interest in Lantheus Holdings Inc (LNTH) Increases By 75.4%
www.americanbankingnews.com - December 31 at 4:22 AM
Lantheus (LNTH) Raised to "Buy" at BidaskClubLantheus (LNTH) Raised to "Buy" at BidaskClub
www.americanbankingnews.com - December 28 at 4:10 PM
Lantheus Holdings, Inc. is trading above its 50 day moving average : LNTH-US : December 28, 2017Lantheus Holdings, Inc. is trading above its 50 day moving average : LNTH-US : December 28, 2017
finance.yahoo.com - December 28 at 10:32 AM
Lantheus (LNTH) Lowered to "Buy" at BidaskClubLantheus (LNTH) Lowered to "Buy" at BidaskClub
www.americanbankingnews.com - December 25 at 3:48 PM
Annual JP Morgan Healthcare Conference - Business Wire (press release)Annual JP Morgan Healthcare Conference - Business Wire (press release)
www.businesswire.com - December 21 at 5:02 PM
Lantheus Holdings, Inc. to Present at the 36th Annual J.P. Morgan Healthcare ConferenceLantheus Holdings, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 21 at 9:52 AM
Lantheus Holdings Inc (LNTH) Receives Average Recommendation of "Hold" from AnalystsLantheus Holdings Inc (LNTH) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 20 at 1:58 AM
BidaskClub Lowers Lantheus (LNTH) to HoldBidaskClub Lowers Lantheus (LNTH) to Hold
www.americanbankingnews.com - December 19 at 6:46 AM
Lantheus Holdings, Inc. – Value Analysis (NASDAQ:LNTH) : December 15, 2017Lantheus Holdings, Inc. – Value Analysis (NASDAQ:LNTH) : December 15, 2017
finance.yahoo.com - December 15 at 5:29 PM
ETFs with exposure to Lantheus Holdings, Inc. : December 14, 2017ETFs with exposure to Lantheus Holdings, Inc. : December 14, 2017
finance.yahoo.com - December 14 at 5:32 PM
Lantheus Holdings, Inc. breached its 50 day moving average in a Bullish Manner : LNTH-US : December 14, 2017Lantheus Holdings, Inc. breached its 50 day moving average in a Bullish Manner : LNTH-US : December 14, 2017
finance.yahoo.com - December 14 at 10:00 AM
Zacks: Analysts Expect Lantheus Holdings Inc (LNTH) to Post $0.16 EPSZacks: Analysts Expect Lantheus Holdings Inc (LNTH) to Post $0.16 EPS
www.americanbankingnews.com - December 12 at 3:24 AM
Lantheus (LNTH) Downgraded by ValuEngineLantheus (LNTH) Downgraded by ValuEngine
www.americanbankingnews.com - December 3 at 7:58 AM
Lantheus (LNTH) & IRIS International (IRIS) Financial SurveyLantheus (LNTH) & IRIS International (IRIS) Financial Survey
www.americanbankingnews.com - December 1 at 5:10 PM
Free Research Report as Align Technology Posted Strong Q3 Results and Diluted EPS Surged 60.32%Free Research Report as Align Technology Posted Strong Q3 Results and Diluted EPS Surged 60.32%
finance.yahoo.com - November 29 at 9:58 AM
Lantheus Holdings, Inc. (LNTH) Sees Significant Decrease in Short InterestLantheus Holdings, Inc. (LNTH) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - November 29 at 2:38 AM
Lantheus Holdings, Inc. (LNTH) Expected to Announce Quarterly Sales of $78.45 MillionLantheus Holdings, Inc. (LNTH) Expected to Announce Quarterly Sales of $78.45 Million
www.americanbankingnews.com - November 26 at 12:32 PM
Lantheus Holdings, Inc. (LNTH) Given Consensus Rating of "Buy" by BrokeragesLantheus Holdings, Inc. (LNTH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - November 25 at 2:14 AM
Lantheus Holdings, Inc. (LNTH) Expected to Post Earnings of $0.16 Per ShareLantheus Holdings, Inc. (LNTH) Expected to Post Earnings of $0.16 Per Share
www.americanbankingnews.com - November 24 at 5:14 AM
ETFs with exposure to Lantheus Holdings, Inc. : November 20, 2017ETFs with exposure to Lantheus Holdings, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 4:23 PM
Timothy G. Healey Sells 11,314 Shares of Lantheus Holdings, Inc. (LNTH) StockTimothy G. Healey Sells 11,314 Shares of Lantheus Holdings, Inc. (LNTH) Stock
www.americanbankingnews.com - November 17 at 10:49 PM
Lantheus Medical Imaging, Inc -- Moodys: Lantheus term loan repricing proposal is credit positiveLantheus Medical Imaging, Inc -- Moody's: Lantheus' term loan repricing proposal is credit positive
finance.yahoo.com - November 17 at 7:01 PM
Insider Selling: Lantheus Holdings, Inc. (LNTH) Insider Sells 11,917 Shares of StockInsider Selling: Lantheus Holdings, Inc. (LNTH) Insider Sells 11,917 Shares of Stock
www.americanbankingnews.com - November 16 at 4:48 PM
First Week Of November 17th Options Trading For Lantheus Holdings (LNTH)First Week Of November 17th Options Trading For Lantheus Holdings (LNTH)
www.thestreet.com - November 9 at 12:36 AM
ETFs with exposure to Lantheus Holdings, Inc. : November 8, 2017ETFs with exposure to Lantheus Holdings, Inc. : November 8, 2017
finance.yahoo.com - November 8 at 7:33 PM
Lantheus Holdings, Inc. :LNTH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017Lantheus Holdings, Inc. :LNTH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
finance.yahoo.com - November 8 at 2:29 PM
Lantheus Holdings, Inc. (LNTH) PT Raised to $27.00Lantheus Holdings, Inc. (LNTH) PT Raised to $27.00
www.americanbankingnews.com - November 5 at 9:40 AM
Credit Suisse Group Increases Lantheus Holdings, Inc. (LNTH) Price Target to $23.00Credit Suisse Group Increases Lantheus Holdings, Inc. (LNTH) Price Target to $23.00
www.americanbankingnews.com - November 5 at 9:40 AM
Lantheus Holdings, Inc. (LNTH) Announces Quarterly  Earnings Results, Beats Estimates By $0.04 EPSLantheus Holdings, Inc. (LNTH) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - November 3 at 9:50 PM
First Week Of LNTH April 2018 Options TradingFirst Week Of LNTH April 2018 Options Trading
www.thestreet.com - November 3 at 3:20 PM
Lantheus Holdings, Inc. Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 GuidanceLantheus Holdings, Inc. Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 Guidance
finance.yahoo.com - November 3 at 3:20 PM
Lantheus Holdings beats 3Q profit forecastsLantheus Holdings beats 3Q profit forecasts
finance.yahoo.com - November 3 at 3:20 PM
Edited Transcript of LNTH earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of LNTH earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 3 at 3:20 PM
Lantheus Holdings, Inc. (LNTH) Receives Consensus Recommendation of "Buy" from BrokeragesLantheus Holdings, Inc. (LNTH) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 31 at 1:34 AM
Lantheus Holdings Reaches Analyst Target PriceLantheus Holdings Reaches Analyst Target Price
www.thestreet.com - October 31 at 1:23 AM
Lantheus Holdings, Inc. to Present at the 26th Annual Credit Suisse Healthcare ConferenceLantheus Holdings, Inc. to Present at the 26th Annual Credit Suisse Healthcare Conference
finance.yahoo.com - October 25 at 6:50 AM
Lantheus Holdings, Inc. (LNTH) to Release Earnings on MondayLantheus Holdings, Inc. (LNTH) to Release Earnings on Monday
www.americanbankingnews.com - October 23 at 10:02 AM
Lantheus Holdings to Host Third Quarter 2017 Earnings Conference Call on November 2, 2017 at 4:30 p.m. Eastern TimeLantheus Holdings to Host Third Quarter 2017 Earnings Conference Call on November 2, 2017 at 4:30 p.m. Eastern Time
finance.yahoo.com - October 20 at 5:16 AM
Your Daily Pharma Scoop: AstraZenecas Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?Your Daily Pharma Scoop: AstraZeneca's Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?
seekingalpha.com - October 18 at 8:26 PM
Your Daily Pharma Scoop: AZNs Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?Your Daily Pharma Scoop: AZN's Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?
seekingalpha.com - October 18 at 3:24 PM

SEC Filings

Lantheus (NASDAQ:LNTH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Lantheus (NASDAQ:LNTH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Lantheus (NASDAQ LNTH) Stock Chart for Monday, January, 22, 2018

Loading chart…

This page was last updated on 1/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.